In situ synthesis of Prussian blue particles

In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar system for in vivo Cs+ uptake Cyril Lavaud, Marilyn Kajdan, Elsa Compte, Jean-Claude Maurel, Joséphine Lai Kee Him, Patrick Bron, Erwan Oliviero, Jérôme Long, Joulia Larionovaa...

Systemic delivery of P42 peptide

Systemic delivery of P42 peptide: a new weapon to fight Huntington’s disease   Yoan Arribat, Yasmina Talmat-Amar, Alexia Paucard, Pierre Lesport, Nathalie Bonneaud, Caroline Bauer, Nicole Bec, Marie-Laure Parmentier, Lorraine Benigno, Christian Larroque, Patrick...
Bace1 inhibition Translational Psychiatry 2017

Bace1 inhibition Translational Psychiatry 2017

BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology EN Wilson, S Do Carmo, MF Iulita, H Hall, A Ducatenzeiler, AR Marks, S Allard, DT Jia, J Windheim and AC Cuello. Lithium is first-line therapy for bipolar...
Pipeline

Pipeline

Products developed under classical NDA or 505/b(2) pathways   Research Preclinical Phase 1 Phase 2 NDA Filed NP03 Alzheimer  •••••••••••   •••••••••••   •••••••••••>     NP03 Huntington   •••••••••••   •••••••••••   •••••••••••>     NP01 Type 2 Diabetes...